Comparative analysis of microsatellite instability-high (MSI-H) BRAF V600E-mutated versus MSI-H BRAF wild type colorectal cancers (CRC), including tumor microenvironment (TME), associated genomic alterations, and immunometabolomic biomarkers.

Authors

Mohamed Salem

Mohamed E. Salem

Levine Cancer Institute, Atrium Health, Charlotte, NC

Mohamed E. Salem , Scott Kopetz , Sherif Mohamed El-Refai , Josep Tabernero , Frank A. Sinicrope , Jeanne Tie , Thomas J. George , Eric VanCutsem , Elizabeth Mauer , Sara Lonardi , Thierry Andre , Michael J. Overman , David Foureau

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Molecular Diagnostics and Imaging

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3066)

DOI

10.1200/JCO.2022.40.16_suppl.3066

Abstract #

3066

Poster Bd #

58

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Gastrointestinal Cancers Symposium

Genomic landscape of <em>ERBB2/3</em> alterations in colorectal cancer: Comutations, immuno-oncology biomarkers, and consensus molecular subtype.

Genomic landscape of ERBB2/3 alterations in colorectal cancer: Comutations, immuno-oncology biomarkers, and consensus molecular subtype.

First Author: Jeanne Tie

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Charac­terizing the genomic landscape of <em>POLE/POLD1</em>-mutated colorectal adenocarcinoma.

Charac­terizing the genomic landscape of POLE/POLD1-mutated colorectal adenocarcinoma.

First Author: Tucker Coston

Poster

2020 ASCO Virtual Scientific Program

The landscape of <em>MAP3K1</em>/<em>MAP2K4 </em>alterations in gastrointestinal (GI) malignancies.

The landscape of MAP3K1/MAP2K4 alterations in gastrointestinal (GI) malignancies.

First Author: Matthew K Stein